MarketWatch

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth

TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem(TM) is delighted to announce the appointment of skilled ...
Business Insider

TreeFrog Therapeutics and Invetech Expand Partnership to Transition High-throughput Stem Cell Encapsulation Technology to GMP System for Commercial-scale Cell Therapy Manufacturing

BORDEAUX, France and SAN DIEGO, Oct. 7, 2020 /PRNewswire/ -- TreeFrog Therapeutics, a French biotech leveraging a unique cell manufacturing technology to advance a pipeline of cell therapies with mass ...
WFLA News Channel 8

TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY ...

- Treefrog will present two posters on their cell therapy program in Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ - TreeFrog is a cell therapy company with a lead ...
Business Wire

TreeFrog Publishes Results of First Successful Bioproduction of a Parkinson’s Disease Cell Therapy in Scalable Bioreactor in Neurotherapeutics Journal

Publication demonstrates the cell therapy product for Parkinson’s Disease overcomes most complex challenges in bioproduction, while demonstrating full behavioral recovery in pre-clinical model ...
Business Wire

TreeFrog Therapeutics Enters Into Pioneering Research Collaboration in Immuno-Oncology With the University of Pittsburgh

BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics has announced a research collaboration with the University of Pittsburgh focused on the potential of tertiary lymphoid structures (TLS) in ...

TreeFrog Therapeutics: TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson's Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinso ...
Fox 5 San Diego

GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic NK-like Cells Against Solid Tumors

FUKUOKA, Japan and BORDEAUX, France, Feb. 15, 2023 (GLOBE NEWSWIRE) -- GAIA BioMedicine, a Japan-based clinical-stage company pioneering allogeneic NK-like cell therapies against solid tumors, and ...
BioWorld

Treefrog Therapeutics takes a big leap with $75M series B round

DUBLIN – Treefrog Therapeutics SA closed a $75 million series B round this week, which will help to increase its reach and its profile, as it pursues its highly ambitious objective to drive the ...
Pharmabiz

TreeFrog Therapeutics to present new preclinical data on TFG-001, a 3D neural microtissue cell therapy, at the 7th World Parkinson’s Conference

TreeFrog Therapeutics to present new preclinical data on TFG-001, a 3D neural microtissue cell therapy, at the 7th World Parkinson’s Conference: Bordeaux, France Tuesday, May 26 ...
FOX40 News

Umoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing Ex Vivo Allogeneic Therapies in Immuno-Oncology

SEATTLE and PESSAC, France, June 10, 2022 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells to treat ...
Agence France-Presse

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World ...